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Background:  The prognostic value of SPECT myocardial perfusion imaging (MPI) is well established. There are limited data on whether 
changes in perfusion defect size (PDS) on serial MPIs track directional changes in outcome.
methods:  We studied 698 patients (61±11 yrs, 53% male, 48% diabetes, 25% MI, 49% prior CR) who underwent 2 regadenoson MPIs 
(16±9 months between MPIs). The MPIs were analyzed side-by-side using an automated software program to evaluate for the presence 
and change in PDS. Improvement in PDS was defined as a reduction ≥ 5% of left ventricle. The primary outcome was a composite of 
death, myocardial infarction (MI) and coronary revascularization (CR).
results:  The primary outcome occurred in 167 patients (24%) during 24±16 months of follow-up after second MPI (8% death, 9% MI, 15% 
CR). The MPIs were normal in both studies in 399 (57%, Group1), showed improvement in 94 (14 %, Group 2, PDS 15±16 vs. 28±18%) 
and no change or worsening in 205 patients (29%, Group 3, 28±17 vs. 20±17%). The best outcomes were seen in Group 1 and the worst 
in Group 3 (p<0.001, Figure). Similar trends were seen for the components of the primary outcome (p=0.04 for death, p<0.001 for MI, 
p<0.001 for CR). In a Cox-regression model that adjusted for baseline factors including PDS and LVEF on initial MPI, the hazard ratios for 
primary outcome were 1.92 (p=0.03) and 3.7 (p<0.001) for Groups 2 and 3 compared to Group 1.
conclusion:  Changes in PDS on serial MPIs provide prognostic information. Serial MPIs can be used to guide patient management. 
